Business
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has engaged an International Communications Consultant, and granted Incentive Stock Options and Restricted Share
About this update from Izotropic Corp.
[{"type":"text","content":"Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has engaged an International Communications Consultant, and granted Incentive Stock Options and Restricted Share Units to Directors, Advisors, and Key Consultants.","length":571,"tagName":"p"},{"type":"text","content":"International Communications Consultant","length":39,"tagName":"p"},{"type":"text","content":"Izotropic has engaged JG Global Communications, led by Mr. James Gagnon, to represent the Company as its International Communications Consultant.","length":145,"tagName":"p"},{"type":"text","content":"Mr. Gagnon brings over two decades of experience in international finance and investor relations, has raised over $100 million in private capital, and has built an extensive global database of investor contacts, particularly across Asia and Europe. His multilingual capabilities including fluency in Mandarin Chinese and conversational ability in several other languages position him well to engage across key global markets. These efforts are aligned with Izotropic's longer-term commercialization strategy, which includes the planned global launch of IzoView, with particular attention to underserved and developing regions where breast cancer incidence is rising, and early detection technologies are in high demand.","length":723,"tagName":"p"},{"type":"text","content":"In the role of International Communications Consultant, JG Global Communications will lead proactive outbound investor communications and global outreach efforts on behalf of Izotropic, with a focus on increasing awareness of Izotropic's technology and value proposition; building relationships with individual investors, brokers, family offices, and healthcare-focused funds; and identifying new sources of investor interest that to impact market investment and financing activities while increasing global recognition of the Company's mission and technologies.","length":570,"tagName":"p"},{"type":"text","content":"As a long-time shareholder of the Company, ...